DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Schuler PJ, Harasymczuk M, Visus C. et al.
Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Clinical cancer research: an official journal of the American Association for Cancer Research 2014;
20: 2433-2444

Download Bibliographical Data

Search in:
Access: